More than 20,000 registrants gathered in Orlando from April 14 to April 19 to discuss the most recent developments in cancer research. Total registration, including virtual attendees, was 21,700. The meeting, which had the theme” Advancing the Frontiers of Science and Medicine,” covered the full spectrum of cancer research, from cancer prevention and early detection to survivorship, population science to disparities, and cutting-edge basic science and practice-changing clinical studies.
At the meeting this year, 243 clinical trials set a record, including 16 Phase III trials that may pave the way for novel, potentially life-saving cancer treatments.
630 speakers from 25 different countries were invited to the meeting. The speakers reflected the growing diversity of our membership, with a significant percentage coming from women( 49 %), minorities( 35 %), and early-career scientists( 9 %).
Nearly 300 presentations were live-streamed, and they are still accessible to registered attendees through July 19.
19 awards, lectureships, and prizes were given out at the meeting in recognition of population scientists, laboratory researchers, physician-scientists who have significantly advanced our knowledge of the diagnosis, prevention, or treatment of cancer. & nbsp,
Rodney and Erika McLeod, who also contributed their voices and energy to the AACR Special Program for High School Students, were among the 605 participants who put on running shoes for the Research 5K Run / Walk. Through sponsorships and peer-to-peer fundraising, the 5K raised$ 163,419 for cancer research.
More than 4,700 media clips were produced as a result of the Annual Meeting, which was covered by more than 220 media representatives. Among the many news outlets that covered the event were the Wall Street Journal, CNN, NBC News, and CBS Evening News as well as an mRNA-individualized cancer vaccine.
This article, along with many others, were published in Cancer Research Catalyst, a publication that released educational articles prior to, during, and following the Annual Meeting. We’ll keep using the information we learned at the meeting to inform our upcoming stories. But for now, here’s another look in case you missed any of our earlier posts.
Five Things You Need to Know at the 2023 AACR Annual Meeting
Welcome to the Global Scholars Training Program
The Opening Ceremony Announces Extraordinary Science
Understanding the Role of Immune Suppression in Brain Metastases
Shared National Cancer Plan by NCI Director
The scope of cancer research is covered in the opening plenary.
Targeted Therapies for Pediatric Cancer: The Past, Present, and Future
Getting Through the Obstacles of Cancer Treatment While Pregnant
Patients with lung, liver, and biliary tract cancers can find hope in Phase III clinical trials.
The numerous facets of cancer early detection and prevention
Immune Ecosystems Demystifying
Creating, focusing on, and delivering novel cancer medications
Treatment Improvements for Patients with Types of Rare Melanoma
Research Breakthroughs and Future Steps in Closing Plenary Highlights
Rodney McLeod, a star of the NFL, and Erika are partners with the AACR to support cancer research.
Part 1 of” Increasing Diversity in Clinical Trials”: Trial Design
Part 2 of Increasing Diversity in Clinical Trials: Community Engagement
First published on American Association for Cancer Research( AACR ) was the article titled” AACRA Annual Meeting 2023: A Recap of ACR Blog Posts.”